Brief: Nynomic Major Order Confirms Considerable Growth Potential
15/05/2020 09:03
May 15 (Reuters) - NYNOMIC AG M7UG.DE :
* MAJOR ORDER FROM AN EXISTING CUSTOMER CONFIRMS
CONSIDERABLE
GROWTH POTENTIAL IN THE MEDICAL PRODUCTS SEGMENT
* ADHERES TO THE ANNUAL FORECAST FOR 2020 OF MORE THAN EUR
70.0
MILLION IN CONSOLIDATED SALES (PREVIOUS YEAR: APPROX. EUR 64.8
MILLION) WITH AN EBIT MARGIN OF OVER 10% (PREVIOUS YEAR: 10%)
* THIS FOLLOW-UP ORDER WILL COVER A TERM OF AROUND TWO YEARS
WITH
A SALES VOLUME OF AROUND EUR 14.0 MILLION
Source text for Eikon: ID:nEQsKCdxa
Further company coverage: M7UG.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;;))